Navigation Links
Medicsight PLC Presents New Data at RSNA 2008 Further Supporting Relevance of Computer-Aided Detection (CAD) and Image Analysis Software in Early Colon Cancer Screening and Diagnosis
Date:12/3/2008

Chicago, Dec. 3 /PRNewswire/ -- Medicsight PLC, an industry leader in and principal developer of Computer-Aided Detection (CAD) and medical image analysis software today announced clinical results from a new study that demonstrated CAD significantly increased the sensitivity of readers in the detection of colorectal cancers in multi-row detector CT (MDCT) colonography (CTC). The results also demonstrate that when both expert and non-expert CTC readers used CAD, it increased their sensitivity in detecting and diagnosing colorectal cancers. Medicsight presented data from this study and from additional abstracts that demonstrate the clinical relevance of CAD in early detection and diagnosis of colon cancer at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) being held through December 5, 2008 in Chicago, IL, USA.

The study (Abstract # SSM10-06: Colorectal Cancers: Effect of Computer-aided Detection in Multirow Detector CT-Colonography - [December 3, 3:50 PM CST]), conducted in Beijing, China, included 60 patients previously diagnosed with colorectal cancers. The patient data was retrospectively reviewed, first without CAD and then with CAD, by four radiologists (two expert and two non-expert radiologists) blinded to colonography and pathology findings. Results showed that CAD increased the sensitivity of expert readers from 80% to 93% (P=0.01) and 97% (P=0.007), and the sensitivity of non-expert readers from 73% and 67% to 90% (P=0.008, P=0.001), respectively.

Medicsight has recently submitted its application for 510(k) clearance to the U.S. Food and Drug Administration (FDA) for its product, ColonCAD(TM), an advanced CAD algorithm used to analyze CT scans of the colon and automatically highlight suspicious areas that may be indicators of disease.

"ColonCAD is fast becoming one of the most clinically validated software applications in medi
'/>"/>

SOURCE Medicsight PLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. MGT Capital Investments, Inc. is Delighted with the Announcement of Medicsights Commercial Agreement with Toshiba PACS Division
2. Medicsight Announces Appointment of NM Rothschild & Sons Limited as Corporate Adviser
3. Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
4. Medicsight Announces New Global Marketing Partnership with Ziosoft Unveiled at RSNA 2008
5. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
6. The Art Of Maternity(TM) at Destination Maternity(R) Presents A Sacred Passage Into Motherhood; the Art of Belly Masking to Belly Casting
7. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
8. VNUS Medical Technologies Presents at William Blair Small-Cap Growth Stock Conference
9. NARSAD - Worlds Leading Mental Health Research Charity - Presents 19th Annual New York Mental Health Symposium, Oct. 19th & 20th
10. Retirement Living TV Presents Sex, Drugs and Rock N Roll
11. AviaraDx Presents at 2007 BIOCOM Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Evaluation and treatment cli... Woodstock (Vocus) November 25, 2009 -- Cen...sal vaccines and H1N1 vaccine shots at four Centeg...other shipment of vaccine has arrived. The clinics...ake and McHenry and will be open as follows: , ...
(Date:11/25/2009)...ivors often plagued by neurological symptoms, stud...ay News) -- Neurological side effects are among th...of testicular cancer who were treated with cisplat... The study included 1,409 Norwegian men treated fo...94 who took part in a follow-up survey conducted f...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/-- MISSIONSkincare &...millionforSt.Jude.AspartofGNC,sannualSt.Jude Thank...MISSIONSkincare,s new SUPER-C(TM)LipBalm willbed...portunitytomakea$1,$5or$10donationatcheckoutatoneo...aisemorethan$1millionforSt.Judeduringtheir2009 Tha...
(Date:11/25/2009)..., LittleImprovementShownforthe4thStraightYear ... Today,LungCancerAlliance-Georgia(LCA-GA)issuedth...ssessmentofprogressbeingmadeagainstthislethaldisea...Alliance(LCA),theonlynationalorganizationdedicated...ingwithoratriskforlungcancer. ,, (Logo: http://...
(Date:11/25/2009)...drug used to treat colorectal cancer also can reve...ed first-line therapy for the disease, researchers...is week. , Mntrier,s disease causes thickening of... and vomiting, as well as anemia and swelling in t...re at increased risk for gastric cancer. Previousl...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...atic New Study Presented in Congressional Briefing...which Congress prepared to vote on the Obama admin...s package, the nation,s largest organization of re... the nation,s healthcare crisis overnight. , , In...
... the National Family Planning and Reproductive Hea... to recent reports federal funding for family plan...essional Budget Office (CBO) the Family Planning M... that have flooded America,s airwaves and papers o...
...A MONICA, Calif., Jan. 28 Consumer Watchdog warne... nursing home worker unions in California will lea...s the agreements negotiated by SEIU tend to put th...of caregivers to blow the whistle on quality of ca...
...avioral weight-loss programs can be an effective w... overweight or obese, according to a study led by ...rancisco. , Volunteer participants in the Program...continence episodes, according to the study. Findi...
... Behavioral weight-loss progra...tinence in women who are overweight or obese, acco...ity of California, San Francisco. , ...ght or obese, according to a study led by research...
...state-of-the-art facility, located just outside of... environment for the professional development and ..., GLENDALE, Ariz., Jan. 28 Today, Grifols SA (Gri...e, Arizona. The Academy is an 8,500 square foot f...
Other Medicine News:Health News:Nurses to Congress: Expanding Medicare Could Reverse Job Losses, and Repair Our Broken Healthcare System and Safety Net 2Health News:Nurses to Congress: Expanding Medicare Could Reverse Job Losses, and Repair Our Broken Healthcare System and Safety Net 3Health News:Get the Facts the House Republicans Don't Want You to Have 2Health News:Weight loss reduces incontinence in obese women, UCSF study shows 2Health News:Weight Loss Reduces Incontinence In Obese Women, UCSF Study Shows 2Health News:Weight Loss Reduces Incontinence In Obese Women, UCSF Study Shows 3Health News:Grifols Inaugurates the GRIFOLS ACADEMY OF PLASMAPHERESIS in Glendale, Arizona 2Health News:Grifols Inaugurates the GRIFOLS ACADEMY OF PLASMAPHERESIS in Glendale, Arizona 3
(Date:11/24/2009)...-FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRML...ndDisclosureStatementtoday,November24,2009,withthe...e.AhearingtoconsiderapprovaloftheDisclosureStateme...ringontheconfirmationofthePlanscheduledforJanuary7...msinfull.ThePlanisexpected,ifapproved,toallowholde...
(Date:11/24/2009)....24/PRNewswire/-- EisaiInc.andPfizerIncannouncedt...ceptedforreviewEisai,sNewDrugApplication(NDA)foron...se)tabletsforthetreatmentofmoderatetosevereAlzheim...ns23mgofdonepezilHClinanextendedrelease,matrix-typ...aseofthedrug.TheNDAisbasedonahead-to-headclinicals...
(Date:11/24/2009)...ire-FirstCall/--ThoratecCorporation(Nasdaq: THOR )...pporttherapiestosave,supportandrestorefailingheart...lPiperJaffrayHealthCareConferenceonTuesday,Decembe...ieffinancialofficer,willprovideanupdateonthecompan...,PacificStandardTime). ,, Thepresentationwillbe...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3IWillAgain com Launches Online Community for Athletes Overcoming Accident Illness or Injury 61623 1IWillAgain com Launches Online Community for Athletes Overcoming Accident Illness or Injury 61623 2Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 61619 1Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 61619 2Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 61619 3Knome Launches First Platform Agnostic Human Genome Sequencing and Analysis Service for Researchers 14898 1Knome Launches First Platform Agnostic Human Genome Sequencing and Analysis Service for Researchers 14898 2Knome Launches First Platform Agnostic Human Genome Sequencing and Analysis Service for Researchers 14898 3
... Findings Show Cystic Fibrosis Patients Cough More... -, SOUTH PLAINFIELD, N.J., May 21 PTC Th...ggesting that the quantification of cough,frequenc...e in cystic,fibrosis (CF). Cough is one of the mos...s in CF. According to data presented today at the,...
... Data Presented at American Urological Association... 21 Researchers,from Dendreon Corporation (Nasdaq...rating the potential of D-3263, Dendreon,s orally ...(a transmembrane cation channel protein also,known... (BPH)., The abstract (#2041), "Preclinical Valid...
Other Medicine Technology:PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 2PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 4Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 2Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 3Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia 4
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: